Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06006741 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06006741 · ClinicalTrials.gov record · last posted 2026-08-26

Universal CAR-T Cells Targeting Multiple Myeloma

StatusNot Yet Recruiting
PhasePhase 1
Started2027-06-30
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The aim of this study is to assess the feasibility, safety and efficacy of universal CAR T cells targeting multiple myeloma. Another goal of the study is to learn more about the persistence and function of the universal CAR T cells in the body.

Protocol amendment history 3 changes detected by DataLookout

2026-08-27
Trial status changed: Recruiting → Not Yet Recruiting
2026-08-27
Primary completion pushed: 2026-09-30 → 2028-07-01
2026-08-27
Completion pushed: 2026-12-31 → 2028-12-31
Trial Details
NCT Number NCT06006741
Lead Sponsor Shenzhen Geno-Immune Medical Institute
Conditions Multiple Myeloma in Remission
Enrollment 20 participants
Start Date 2027-06-30
Primary Completion 2028-07-01 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-26